Rasagiline Withdrawal Syndrome in Parkinson’s Disease

Rasagiline Withdrawal Syndrome in Parkinson’s Disease

Parkinson’s disease (PD) patients using dopamine agonists can develop withdrawal symptoms, referred to as dopamine agonist withdrawal syndrome (DAWS), under dose tapering or discontinuation of these drugs. DAWS includes a severe stereotypical cluster of psychiatric and psychological symptoms encompa...

Full description

Bibliographic Details
Main Authors: Paolo Solla, Tommaso Ercoli, Carla Masala, Gianni Orofino, Laura Fadda, Davide Giacomo Corda, Ignazio Roberto Zarbo, Mario Meloni, Elia Sechi, Caterina Francesca Bagella, Giovanni Defazio
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Brain Sciences
Subjects:
rasagiline
DAWS
Parkinson’s disease
Online Access:https://www.mdpi.com/2076-3425/12/2/219

Internet

https://www.mdpi.com/2076-3425/12/2/219

Similar Items